# Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

> **NCT00662636** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 27 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** dasatinib
- **DRUG:** lapatinib ditosylate
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00662636
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2014-12-18
- **Final completion:** 2014-12-18
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662636, "Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00662636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*